Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem.

Barnes-Weise, Julia; Santos Rutschman, Ana; Adler, Reid

Barnes-Weise, Julia; Santos Rutschman, Ana; Adler, Reid.

Barnes-Weise J; Global Healthcare Innovation Alliance Accelerator, Durham, North Carolina, USA.
Santos Rutschman A; Institute for Vaccine Science and Policy, Saint Louis University, Saint Louis, Missouri, USA ana.rutschman@slu.edu.
Adler R; Center for Health Law Studies, Saint Louis University, Saint Louis, Missouri, USA.

J Epidemiol Community Health ; 76(4): 317-318, 2022 04.

Article in English | MEDLINE | ID: covidwho-1685691

Subject(s)

COVID-19 Vaccines; COVID-19; COVID-19/prevention & control; Humans; Intellectual Property; SARS-CoV-2; Vaccination

Keywords

health policy; international health; vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Epidemiol Community Health Year: 2022 Document Type: Article Affiliation country: Jech-2021-218409

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google